SEC Form 4 · accession 0001127602-17-009708
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Helena Foulkes
Officer — EVP, President-CVS Pharmacy
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Stock UnitF1 | Feb 28, 2017 | A | 15,512 | $80.58 | A | 51,389 | D | |
| Common Stock | holding | — | — | — | 42,398 | D | ||
| Common Stock (restricted) | holding | — | — | — | 41,172 | D | ||
| ESOP Common Stock | holding | — | — | — | 4,071 | I | By ESOP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer.